Department of Laboratory, Children's Hospital of Nanjing Medical University, Nanjing, China.
SICU, Children's Hospital of Nanjing Medical University, Nanjing, China.
Worldviews Evid Based Nurs. 2019 Dec;16(6):485-494. doi: 10.1111/wvn.12410. Epub 2019 Nov 19.
The role of donated breast milk and formula feeding in very low birth weight infants (VLBWIs) remains unclear.
The objective for this study was to evaluate the efficacy and safety of breast milk and formula for feeding VLBWIs.
A comprehensive search of PubMed databases was conducted on November 30, 2018, to identify related randomized controlled trials (RCTs). Pooled odds ratio (OR) and mean differences (MD) with 95% confidence intervals (CI) were calculated using either a fixed or random-effects model.
Seven RCTs with a total of 876 infants were included. The formula showed more advantages in increasing infant weight (MD = -6.58, 95% CI: -11.19 to -1.98) and length (MD = -0.30, 95% CI: -0.41 to -0.20) than donated breast milk, but formula could also significantly increase the risks of necrotizing enterocolitis (OR = 0.33, 95% CI: 0.18 to 0.59) and length of hospital stay (MD = -3.78, 95% CI: -6.84 to -0.72) when compared with donated breast milk. No significant differences on the head circumference gain (MD = -0.16, 95% CI: -0.33 to 0.01), sepsis (OR = 1.21, 95% CI: 0.84 to 1.75), retinopathy of prematurity (OR = 1.22, 95% CI: 0.73 to 2.05) and mortality (OR = 0.84, 95% CI: 0.47 to 1.52) were found.
The donated breast milk shows more advantages in reducing the incidence of NEC and length of hospital stay, but also more disadvantages in increasing the weight and length of VLBWIs and ELBWIs when compared with preterm formula feeding. Currently, there is no solid evidence demonstrating a significant advantage of donated breast milk over formula in the feeding of VLBWIs. Larger-scale RCTs with rigorous designs are needed to elucidate the feeding plans of VLBWIs.
捐赠母乳和配方奶在极低出生体重儿(VLBWI)中的作用仍不清楚。
本研究旨在评估母乳喂养和配方奶喂养 VLBWI 的疗效和安全性。
于 2018 年 11 月 30 日对 PubMed 数据库进行全面检索,以确定相关的随机对照试验(RCT)。使用固定或随机效应模型计算合并优势比(OR)和均数差值(MD)及 95%置信区间(CI)。
纳入 7 项 RCT 共 876 例婴儿。配方奶在增加婴儿体重(MD=-6.58,95%CI:-11.19 至-1.98)和身长(MD=-0.30,95%CI:-0.41 至-0.20)方面较捐赠母乳更有优势,但配方奶也显著增加了坏死性小肠结肠炎(OR=0.33,95%CI:0.18 至 0.59)和住院时间(MD=-3.78,95%CI:-6.84 至-0.72)的风险,与捐赠母乳相比。在头围增长(MD=-0.16,95%CI:-0.33 至 0.01)、败血症(OR=1.21,95%CI:0.84 至 1.75)、早产儿视网膜病变(OR=1.22,95%CI:0.73 至 2.05)和死亡率(OR=0.84,95%CI:0.47 至 1.52)方面,差异无统计学意义。
与早产儿配方喂养相比,捐赠母乳在降低 NEC 发生率和住院时间方面具有更多优势,但在增加 VLBWI 和 ELBWI 的体重和身长方面也具有更多劣势。目前,没有确凿的证据表明捐赠母乳在喂养 VLBWI 方面优于配方奶。需要进行更大规模、设计严谨的 RCT 来阐明 VLBWI 的喂养方案。